Company

BioHarvest Sciences, Inc.

Headquarters: Vancouver, BC, Canada

OTC: CNVCF -0.45%

Market Cap

$109.9 Million

USD as of Jan. 1, 2025

Market Cap History

BioHarvest Sciences, Inc. Categories

Canada Healthcare Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

BioHarvest Sciences, Inc. market capitalization over time

Evolution of BioHarvest Sciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BioHarvest Sciences, Inc.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Stocks & Indices

BioHarvest Sciences, Inc. has the following listings and related stock indices.


Stock: OTC: CNVCF wb_incandescent

Stock: CSE: BHSC wb_incandescent

Stock: FSX: 8MV wb_incandescent

Details

Headquarters:

Two Bentall Centre

Suite 1085 555 Burrard Street

Vancouver, BC V7X 1M8

Canada

Phone: 604 622 1186